Format

Send to:

Choose Destination
See comment in PubMed Commons below
Trends Pharmacol Sci. 2010 Mar;31(3):99-101. doi: 10.1016/j.tips.2009.11.005. Epub 2010 Feb 1.

Impact of poor-quality medicines in the 'developing' world.

Author information

  • 1Wellcome Trust-Mahosot Hospital-Oxford Tropical Medicine Research Collaboration, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR. paul@tropmedres.ac

Abstract

Since our ancestors began trading several millennia ago, counterfeit and substandard medicines have been a recurring problem, with history punctuated by crises in the supply of anti-microbials, such as fake cinchona bark in the 1600s and fake quinine in the 1800s. Unfortunately this problem persists, in particular afflicting unsuspecting patients in 'developing' countries. Poor-quality drugs are a vital (but neglected) public health problem. They contribute to a 'crevasse' between the enormous effort in therapeutic research and policy decisions and implementation of good-quality medicines.

2009 Elsevier Ltd. All rights reserved.

PMID:
20117849
[PubMed - indexed for MEDLINE]
PMCID:
PMC2845817
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk